Archive - March 2021
Efficacy data from US trial for AZ/Oxford vaccine raises concerns over possible ‘incomplete view’
CureVac expands COVID-19 vaccine trial protocol to include variant specification
Roche, Regeneron’s COVID-19 antibody cocktail cuts hospitalisation or death by 70%
Positive late-stage results for Novartis’ radioligand therapy in advanced prostate cancer
Roche ends tominersen study in manifest Huntington’s disease
Researchers identify molecular ‘cookie cutter’ technique for COVID-19 drug discovery
Daiichi Sankyo inks digital partnership for atrial fibrillation
AstraZeneca’s COVID-19 vaccine shows 79% efficacy in US trial